Gül DAĞLAR, Yunus Nadi YÜKSEK, Ahmet Uğur GÖZALAN, Tanju TÜTÜNCÜ, Yeşim GÜNGÖR, Nuri Aydın KAMA

The prognostic value of histological grade in the outcome of patients with invasive breast cancer

Prognostic factors are useful for the prediction of survival in breast cancer patients. According to many studies, tumor size and lymph node stage are the most powerful predictors of tumor behavior. The aim of the present study was to investigate the prognostic value of tumor histological grade. Materials and methods: The study included 214 operable breast cancer patients treated at the same institution that were evaluated to determine the prognostic value of tumor histological grade. Clinico-histopathological features of the patients were also evaluated for overall survival (OS) and disease-free survival (DFS). Results: Tumor histological grade was an independent factor in cancer-specific survival (CSS) and disease-free survival (DFS) (P < 0.001). The prognostic value of histological grade for CSS and DFS was superior to that of all T stages and to pN0, pN1, and pN2 stages (P < 0.001). Conclusion: A classification system including histological grade, as a nodal status-like factor, could be more reliable in predicting breast cancer outcome.

Anahtar Kelimeler:

Key words: Breast neoplasms, prognosis, histological grade; survival

The prognostic value of histological grade in the outcome of patients with invasive breast cancer

Keywords:

Key words: Breast neoplasms, prognosis, histological grade; survival,

PDF

___

Carter CL, Allen C, Heuson D. Relation of tumour size, lymph node status and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181-7.
Van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol 2002; 28: 481-9.
Fisher ER, Anderson S, Tan-Chiu E, Fisher B, Eaton L, Wolmark N. Fifteen-year prognostic discriminants for invasive breast carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol-06. Cancer 2001; 91: 1679-1687.
D’Eredita G, Giardina C, Martellotta M, Natale T, Ferrarese F. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. Eur J Cancer 2001; 37: 591-596.
Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983; 52: 1551-7.
Fisher ER, Constantino J, Fisher B, Redmond C. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol 4) Discriminants for 15 year survival. Cancer 1993; 71: 2141-50.
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
Vincent-Salomon A, Carton M, Zafrani B, Freneaux P, Nicolas A, Massemin B et al. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases. Cancer 2001; 92: 249-256.
Schaapveld M, Otter R, de Vries EG, Fidler V, Grond JA, van der Graaf WT et al. Variability in axillary lymph node dissection for breast cancer. J Surg Oncol 2004; 87: 4-12.
Kim KJ, Huh SJ, Yang JH, Park W, Nam SJ, Kim JH et al. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy. Jpn J Clin Oncol 2005; 35: 126-33.
Frkovic-Grazio S, Bracko M. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. J Clin Pathol 2002; 55: 88-92.
Warwick J, Tabbar L, Vitak B, Duffy SW. Time dependent effects on survival in breast carcinoma: results of 20 years of follow-up from the Swedish two-County Study. Cancer 2004; 100: 1331- 1336.
Kato T, Kameoka S, Kimura T, Nishikawa T, Kobayashi M. Angiogenesis as a predictor of long term survival for 377 Japanese patients with breast cancer. Breast Cancer Res Treat 2001; 70: 65-74.
Tabar L, Duffy SW, Vitak B, Chenn HH, Prevost TC. The natural history of breast carcinoma: what have we learned from screening? Cancer 1999; 86: 449-462.